“Take Two And Call Me in the Morning”
Noted Analgesic Researcher, Dr. Paul Desjardins, Presents Sackler Distinguished Lecture
) Dr. Paul Desjardins |
Dr.
Paul Desjardins, Senior Vice President for clinical analgesic research
at the SCIREX Corporation in Austin, Texas, presented the sixth Dr.
Alvin M. Sackler Distinguished Lecture in Oral Medicine at NYUCD on
Monday, April 21, 2003. Entitled “Advances in Acute Pain Research:
From Dental Pain to Foot Pain,” the lecture was held in the new Rosenthal
Institute for Aesthetic Dentistry. A former Professor of Diagnostic Sciences and of Oral and Maxillofacial surgery and Associate Dean for Academic Affairs at the University of Medicine and Dentistry of New Jersey (UMDNJ) Dental School, Dr. Desjardins holds a dental degree from Tufts University and a Ph.D. in pharmacology from Georgetown University. Dr. Desjardins is a world-renowned investigator in the field of clinical pharmacology and, in particular, the human pharmacology of pain-relieving drugs. In his current position as Senior Vice President at the SCIREX Corporation, Dr. Desjardins is responsible for five clinical research centers throughout the United States and one new center in London, England. His research team of over 135 physicians, dentists, nurses, clinical coordinators, and research staff performs over 40 clinical trials of analgesic drugs per year. The Dr. Alvin M. Sackler Distinguished Lectures in Oral Medicine are supported by an endowment from the Raymond and Beverly Sackler Foundation in honor of Dr. Alvin Sackler, a noted periodontist and researcher in the field of oral medicine. Previous Sackler Distinguished Lecturers have included Dr. Israel Kleinberg, Dr. S. Sigmund Socransky, Dr. Harold Slavkin, and Dr. Robert Genco. |
